Abiopharma

CHEMED CORP (CHE)

Symbol	CHE
Name	CHEMED CORP
Sector	HEALTH CARE
Region	UNDEFINED
Industry	Services-Home Health Care Services
Address	SUITE 2600, CINCINNATI, OH 45202
Telephone	(513)762-6690
Fax	—
Email	—
Website	https://www.chemed.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	—
Description	Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firms revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segments revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States. Additional info from NASDAQ: Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firms revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segments revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

2026-05-01 19:24

📋 KEVIN MCNAMARA (OFFICER) plans to sell 1K shares of Chemed Corporation (at $419.85 each, total $420K) Filed: May 01, 2026 | ID: 029271

2026-05-01 13:23

📋 MCNAMARA KEVIN J (Officer) plans to sell 1K shares of CHEMED CORP (at $420.00 each, total $420K) Filed: May 01, 2026 | ID: 000160

2026-04-29 18:41

New Form SCHEDULE 13G - CHEMED CORP Filed: 2026-04-29 AccNo: 0002100119-26-000304 Size: 7 KB

2026-04-29 13:18

New Form SCHEDULE 13G - CHEMED CORP Filed: 2026-04-29 AccNo: 0002100121-26-000151 Size: 7 KB

2026-04-28 13:00

CHEMED CORP (CHE) Files Form 10-Q

2026-04-23 20:15

Chemed Reports First-Quarter 2026 Results

2026-04-13 13:03

(99% Neutral) CHEMED CORP (CHE) Announces Business Combination

2026-04-13 12:15

Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement

2026-04-09 11:42

New Form DEFR14A - CHEMED CORP Filed: 2026-04-09 AccNo: 0001562762-26-000052 Size: 4 MB

2026-04-06 10:00

New Form DEF 14A - CHEMED CORP Filed: 2026-04-06 AccNo: 0000019584-26-000005 Size: 4 MB

No clinical trials found for this company.

No clinical products found for this company.